• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
Jan Cerny of BHM Group
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • Investments
  • 01 September 2023
Big Ben and British flag London UK
CMA scrutiny of high-leverage PE divestment purchases expected to increase

PE could stand to lose its historic advantage with heightened regulatory baggage

  • Regulation
  • 21 August 2023
Deals and business agreements
Evoco expects portfolio acquisitions, assesses potential exits in 2H23

Switzerland-headquartered GP is currently deploying equity via its EUR 162m Evoco TSE III fund

  • Investments
  • 21 August 2023
Wolfgang de Limburg of Apheon
GP Profile: Apheon builds on family roots, mulls exits and reinvestment opportunities

Belgian GP, formerly known as Ergon, to continue to target family- and entrepreneur-owned European businesses

  • GPs
  • 18 August 2023
Liposuction surgery
Quadrivio to capitalise on baby boomers as it nears wrap for its new EUR 300m fund

The Silver Economy Fund makes its second investment as it highlights trend of GPs doubling down on narrow strategies

  • Buyouts
  • 16 August 2023
Dental implants and dentures
Corus Dental sponsors mandate Houlihan Lokey to review options

Upcoming process for Spain-based dental prosthetics company to launch in September

  • Exits
  • 14 August 2023
Eye surgery equipment
Eurazeo taps Rothschild for DORC exit

Upcoming process for Dutch medical equipment group expected to launch in September

  • Exits
  • 11 August 2023
Laboratory testing services
Synlab remains in talks with Cinven five months after initial approach

Cinven listed lab diagnostics firm in April 2021 at EUR 18 per share and remains its largest shareholder

  • Buyouts
  • 09 August 2023
UK fund closes and launches
WestBridge raises GBP 130m in first close for third fund with debut deal in sight

UK-based PE firm has set GBP 200m hard-cap and target for the vehicle

  • Funds
  • 08 August 2023
Pharma packaging
Triton Partners exploring potential sale of Bormioli Pharma

Italian drug packaging company is likely to draw interest from strategics, plus sponsors with sector experience

  • Exits
  • 07 August 2023
Hand sanitiser
EQT exits Schuelke to Athos-led consortium

The Munich-based family office has been an LP in EQT's funds; joined recent co-investment tickets

  • Exits
  • 07 August 2023
Michael Holgate of Baird Capital
GP Profile: Baird Capital puts lower-middle-market niche and global expansion offering to work

GP’s flexible deal structure proposition resonates particularly well with founders in the current environment, Michael Holgate told Unquote

  • GPs
  • 07 August 2023
Offices opening in Zug in Switzerland
Bregal eyes local deal origination with new Swiss office

GP's third fund is completing its investment period, with fourth fund registered

  • DACH
  • 04 August 2023
Prosthetics and orthopedic care
Blatchford backer CBPE mandates Investec to oversee imminent exit

GP began weighing options for UK-based prosthetics manufacturer last July

  • Exits
  • 03 August 2023
Dental CAD CAM solutions providers
Teasers out for Ardian-backed imes-icore

No formal process has kicked off for the German medtech firm but significant sponsor interest is expected

  • Exits
  • 31 July 2023
Surgery devices
Apax acquires co-controlling stake in Fremman Capital-backed Palex Medical

Deal values Spain-headquartered medical equipment distributor at around EUR 1bn

  • Buyouts
  • 31 July 2023
Pharmaceutical and biotech services providers
Permira early strong contender in Triton-backed Pharmanovia auction

Speciality pharma business sale comes as a number of other large-cap healthcare auctions have faltered

  • Exits
  • 28 July 2023
Nearing the finish line
PAI Partners nears close for EUR 7bn Fund VIII following timeline extension

France-headquartered firm is expected to close the vehicle in November 2023 amid a tough fundraising climate

  • Funds
  • 27 July 2023
Molecular research
Medicxi raises USD 400m to invest in single-focus life sciences companies

GP's fourth fund will deploy USD 10m-USD 20m tickets in narrow indications of unmet need; backed by pharma

  • Venture
  • 27 July 2023
Back on the fundraising trail
Fremman considers return to market in 2024 following newly closed EUR 1bn debut fundraise

Pan-European GP raised its debut fund during the ‘most challenging’ period for debut funds in recent years

  • Funds
  • 26 July 2023
Frederik Fogtdal of Stanley Capital Partners
Stanley Capital Partners hires two in drive for growth

James Sexton and Frederik Fogtdal will join the mid-market healthcare and resource efficiency-focused GP as principal

  • People
  • 24 July 2023
Fundraising in euros
KKA Partners boasts strong US LP showing in latest EUR 230m fund

Small mid-cap investor avoids pure tech businesses and ongoing ‘bubble’

  • Funds
  • 24 July 2023
The Unquote Private Equity Podcast
Unquote Private Equity Podcast: In conversation with... Alex Walsh, Blackstone

Senior Managing Director Alex Walsh discusses topics including his career in the PE industry, LGBTQ+ representation and inclusion, and the current macro environment

  • Industry
  • 24 July 2023
1 2 3
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013